Lab manager: lessons learned from covid-19

Home Lab Manager

Watch our webinar to learn how the COVID-19 pandemic has empowered labs to meet growing diagnostic demands with automation.

The COVID-19 pandemic has brewed the perfect storm for lab managers.

The Institute of Biomedical Science estimates that in 2021, the demand and capability for molecular testing in UK pathology microbiology labs has jumped from around 300,000 a year, to 300,000 every single day.

Unsurprisingly, diagnostic targets are now being regularly missed, lab scientists are overstretched, and human error is increasingly reported in the press.

The Life Sciences sector has learnt the hard way that their way of working needs to be revolutionised. And there is one technology that, having already transformed many industries, promises to help overcome these challenges: Automation.

Watch Nick Pattinson, Head of Lab Automation at Automata, as he shares his thoughts on the immediate impact automation solutions can have within diagnostic labs. Nick discusses how automation can empower diagnostic labs to scale up, ease pressure on exhausted staff, cut costs and minimise mistakes.

Nick is joined by Institute of Biomedical Science Chief Executive David Wells who previously led NHS England’s testing response to Covid-19. Known for his approach to modernising pathology, David and Nick talk about how the industry can meet this unprecedented demand and the potential benefits end-to-end workflow automation system can bring.

Watch our webinars

Cultured Protein Webinar
Getting from R&D to scale, the Cultured Protein commercialization journey

Join our webinar as our panel of experts discuss key routes to production & scale for cultured protein start-ups to meet demand drivers.

Lab Automation for Pathology & Genomics: Work Smarter

Discover valuable insights into the impact of automation in the lab space. Watch the recording with Divya Vijay Pratheek, Msc, Director of Product Growth.

Front Line Genomics Webinar

Watch our latest webinar as Craig Johnston discusses the impact of lab automation on clinical cancer genomics in 2022 and beyond.